On Thursday shares of KeyCorp. (NYSE:KEY) closed at $14.93. Company’s sales growth for last 5 years was -7.60% and EPS growth for next 5 years is recorded as 9.69%. KeyCorp. (NYSE:KEY) declared that Don Kimble, Chief Financial Officer, together with E.J. Burke and Dennis Devine, Co-Presidents of Key Community Bank will present at the Deutsche Bank Global Financial Services Investor Conference in New York City on Tuesday, June 2, 2015, at 8:55 a.m. ET.
Cambrex Corporation. (NYSE:CBM) in last trading activity advanced 2.44% to close at $38.99. Company weekly performance is 4.22% while its quarterly performance stands at 18.62%. Cambrex Corporation. (NYSE:CBM) is -11.83% away from its 52 week high. Cambrex Corporation. (NYSE:CBM) on May 01, 2015, announced results for the first quarter ended March 31, 2015. Highlights included: Sales increased 18% compared to the first quarter of 2014, and increased 27% excluding foreign currency impact, driven by Innovator products and Controlled Substances; EBITDA increased to $18.0 million from $8.4 million in the first quarter of 2014; GAAP Diluted EPS from continuing operations was $0.26 versus $0.04 in the first quarter last year and Adjusted Diluted EPS was $0.29 compared to $0.07 in the same quarter last year; Net Cash improved $22.4 million to $7.9 million compared to Debt, net of cash, of $14.5 million at December 31, 2014.
On last trading day Amedica Corporation (NASDAQ:AMDA) decreased -2.87% to close at $0.22. Its volatility for the week is 10.99% while volatility for the month is 14.18%. AMDA’s sales growth for past 5 years was 196.20% and its EPS growth for past 5 years was -48.40%. Amedica Corporation (NASDAQ:AMDA) monthly performance is -17.26%. Amedica Corporation (Nasdaq:AMDA
) on 5 May, announced financial results for the fourth quarter and full year ended December 31, 2014. Total product revenue increased by 2% during 2014 to $22.8 million, as compared to $22.3 million in 2013. This was primarily attributable to a 41% increase, or $3.2 million, in silicon nitride ceramic product revenue over the prior-year period due to increased market adoption of the Valeo™ spinal interbody devices and the Company’s focus on its core silicon nitride technology.
Teradata Corporation (NYSE:TDC) has 0.90% insider ownership. In last trading activity company’s stock closed at $40.82. Teradata Corporation (NYSE:TDC) has a Zacks Rank #3 (Hold).
On last trading day Pluristem Therapeutics, Inc. (NASDAQ:PSTI) decreased -1.47% to close at $2.69. Its volatility for the week is 3.12% while volatility for the month is 3.70%. PSTI’s EPS growth for past 5 years was 7.80%. Pluristem Therapeutics, Inc. (NASDAQ:PSTI) monthly performance is -7.88%. On 9 May, Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been issued Patent No. EP2366775B1, titled “Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy”, by the European Patent Office. This patent addresses use of adherent stromal cells from placenta or adipose tissue, expanded according to Pluristem’s methods of three dimensional culturing, for treating conditions that may benefit from facilitation of hematopoietic stem cell engraftment.